Skip to main content
· 6/17/1988

Hybritech Incorporated v. Abbott Laboratories

Citations

  • 849 F.2d 1446
  • 7 U.S.P.Q. 2d (BNA) 1191
  • 1988 U.S. App. LEXIS 8337
  • 1988 WL 60245

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

  • holding that the grant oí a preliminary injunction was based on more than an unwarranted presumption of irreparable harm where the district court found the patentee would suffer lost market position and obstructed business relationships in the market
  • noting that a “period of delay” constitutes “one factor to be considered by a district court in its analysis of irreparable harm”
  • concluding injunctive relief under § 283 is governed by the law of the Federal Circuit, not regional circuits
  • concluding injunctive relief under § 283 is governed by the law of the Federal Circuit, not regional circuits
  • affirming a decision not to enjoin the production of infringing hepatitis and cancer test kits
  • affirming a decision not to enjoin the production of infringing hepatitis and cancer test kits

Source: CourtListener parenthetical corpus (CC0).

Judges: Davis, Smith, Baldwin

Read full opinion on CourtListener

Sourced from CourtListener / Free Law Project (CC0).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.